Historical Valuation
Healthequity Inc (HQY) is now in the Undervalued zone, suggesting that its current forward PE ratio of 20.99 is considered Undervalued compared with the five-year average of 35.03. The fair price of Healthequity Inc (HQY) is between 104.19 to 195.81 according to relative valuation methord. Compared to the current price of 98.51 USD , Healthequity Inc is Undervalued By 5.45%.
Relative Value
Fair Zone
104.19-195.81
Current Price：98.51
5.45%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Healthequity Inc (HQY) has a current Price-to-Book (P/B) ratio of 3.65. Compared to its 3-year average P/B ratio of 3.39 , the current P/B ratio is approximately 7.93% higher. Relative to its 5-year average P/B ratio of 3.28, the current P/B ratio is about 11.54% higher. Healthequity Inc (HQY) has a Forward Free Cash Flow (FCF) yield of approximately 5.31%. Compared to its 3-year average FCF yield of 3.86%, the current FCF yield is approximately 37.63% lower. Relative to its 5-year average FCF yield of 3.38% , the current FCF yield is about 56.97% lower.
P/B
Median3y
3.39
Median5y
3.28
FCF Yield
Median3y
3.86
Median5y
3.38
Competitors Valuation Multiple
AI Analysis for HQY
The average P/S ratio for HQY competitors is 4.12, providing a benchmark for relative valuation. Healthequity Inc Corp (HQY.O) exhibits a P/S ratio of 5.65, which is 37.1% above the industry average. Given its robust revenue growth of 7.23%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for HQY
1Y
3Y
5Y
Market capitalization of HQY increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of HQY in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is HQY currently overvalued or undervalued?
Healthequity Inc (HQY) is now in the Undervalued zone, suggesting that its current forward PE ratio of 20.99 is considered Undervalued compared with the five-year average of 35.03. The fair price of Healthequity Inc (HQY) is between 104.19 to 195.81 according to relative valuation methord. Compared to the current price of 98.51 USD , Healthequity Inc is Undervalued By 5.45% .
What is Healthequity Inc (HQY) fair value?
HQY's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Healthequity Inc (HQY) is between 104.19 to 195.81 according to relative valuation methord.
How does HQY's valuation metrics compare to the industry average?
The average P/S ratio for HQY's competitors is 4.12, providing a benchmark for relative valuation. Healthequity Inc Corp (HQY) exhibits a P/S ratio of 5.65, which is 37.10% above the industry average. Given its robust revenue growth of 7.23%, this premium appears unsustainable.
What is the current P/B ratio for Healthequity Inc (HQY) as of Jan 10 2026?
As of Jan 10 2026, Healthequity Inc (HQY) has a P/B ratio of 3.65. This indicates that the market values HQY at 3.65 times its book value.
What is the current FCF Yield for Healthequity Inc (HQY) as of Jan 10 2026?
As of Jan 10 2026, Healthequity Inc (HQY) has a FCF Yield of 5.31%. This means that for every dollar of Healthequity Inc’s market capitalization, the company generates 5.31 cents in free cash flow.
What is the current Forward P/E ratio for Healthequity Inc (HQY) as of Jan 10 2026?
As of Jan 10 2026, Healthequity Inc (HQY) has a Forward P/E ratio of 20.99. This means the market is willing to pay $20.99 for every dollar of Healthequity Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Healthequity Inc (HQY) as of Jan 10 2026?
As of Jan 10 2026, Healthequity Inc (HQY) has a Forward P/S ratio of 5.65. This means the market is valuing HQY at $5.65 for every dollar of expected revenue over the next 12 months.